Effects of oral prednisolone on biomarkers in synovial tissue and clinical improvement in rheumatoid arthritis
Daniëlle M. Gerlag(UCB Pharma (United Kingdom)), Paul P. Tak(Amsterdam UMC Location University of Amsterdam), Maarten C. Kraan(University of Amsterdam), Jasper J. Haringman(Isala), Aeilko H. Zwinderman(GGD Amsterdam), Tom Smeets(Tilburg University), Anthony Nash(AstraZeneca (United Kingdom)), Shethah Morgan(AstraZeneca (United Kingdom)), Peter J. Laud(AstraZeneca (United Kingdom))
Cited by 155
Related Papers
NF-κB: a key role in inflammatory diseases
|Journal of Clinical Investigation|2001|3.9k
Tumor necrosis factor antagonist mechanisms of action: A comprehensive review
|Pharmacology & Therapeutics|2007|1.6k
Genome-wide association study meta-analysis identifies seven new rheumatoid arthritis risk loci
|Nature Genetics|2010|1.3k
Simvastatin with or without Ezetimibe in Familial Hypercholesterolemia
|New England Journal of Medicine|2008|1.2k
Use of uterine artery Doppler ultrasonography to predict pre-eclampsia and intrauterine growth restriction: a systematic review and bivariable meta-analysis
|Canadian Medical Association Journal|2008|718